Foresite Capital Management Iii, LLC Natera, Inc. Transaction History
Foresite Capital Management Iii, LLC
- $37.9 Million
- Q3 2022
A detailed history of Foresite Capital Management Iii, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Foresite Capital Management Iii, LLC holds 159,160 shares of NTRA stock, worth $24.9 Million. This represents 18.41% of its overall portfolio holdings.
Number of Shares
159,160
Previous 159,160
-0.0%
Holding current value
$24.9 Million
Previous $5.64 Million
23.63%
% of portfolio
18.41%
Previous 20.46%
Shares
7 transactions
Others Institutions Holding NTRA
# of Institutions
634Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.93 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.06 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.06 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.05 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$694 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.2B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...